Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic Patients

NCT04318041 is registered in ClinicalTrials.gov with TRB Chemedica as lead sponsor.

NCT NCT04318041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04318041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic Patients
Lead sponsor
TRB Chemedica
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 22, 2020
Completion date
December 31, 2026
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis